Literature DB >> 17636461

Inhibition of nitric oxide-induced apoptosis by nicotine in oral epithelial cells.

Abhijit G Banerjee1, Velliyur K Gopalakrishnan, Jamboor K Vishwanatha.   

Abstract

Development of oral cancer is clearly linked to the usage of smokeless tobacco. The molecular mechanisms involved in this process are however not well understood. Toward this goal, we investigated the effect of smokeless tobacco exposure on apoptosis of oral epithelial cells. Exposure of oral epithelial cells to smokeless tobacco extract (STE) induces apoptosis in a dose-dependent manner, until a threshold level of nicotine is achieved upon which apoptosis is inhibited. 1 mM of nicotine is able to inhibit apoptosis significantly induced by STE in these oral cells. Exposure of cells to nicotine alone has no effect on apoptosis, but nicotine inhibits apoptosis induced by other agents present in STE. In this study we show that, the anti-apoptotic action of nicotine is specifically associated with down-regulation of nitric oxide (NO) production. Using specific inducers of NO, we have demonstrated that inhibition of apoptosis by nicotine is through down-regulation of NO production. Further, we observed that nicotine clearly acts as a sink of NO radicals, shown using peroxynitrite generator (SIN-1) in conjunction or absence of radical scavengers. Nicotine thus causes most damage in transformed epithelial cells as depicted by accumulation of nitrotyrosine in a 3-NT ELISA assay. Inhibition of apoptosis is a hallmark in tumor progression and propels development of cancer. It may further result in functional loss of apoptotic effector mechanisms in the transformed cells. Thus, our data clearly indicates that inhibition of NO-induced apoptosis by nicotine may lead to tobacco-induced oral carcinogenesis, and implies careful development of modalities in tobacco cessation programs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17636461     DOI: 10.1007/s11010-007-9534-2

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  56 in total

1.  Expression of prostaglandin endoperoxide H synthase-2 induced by nitric oxide in conditionally immortalized murine colonic epithelial cells.

Authors:  J M Mei; N G Hord; D F Winterstein; S P Donald; J M Phang
Journal:  FASEB J       Date:  2000-06       Impact factor: 5.191

Review 2.  Inhibition of cyclooxygenase: a novel approach to cancer prevention.

Authors:  K Subbaramaiah; D Zakim; B B Weksler; A J Dannenberg
Journal:  Proc Soc Exp Biol Med       Date:  1997-11

Review 3.  The molecular regulation of apoptosis and implications for radiation oncology.

Authors:  K R Blank; M S Rudoltz; G D Kao; R J Muschel; W G McKenna
Journal:  Int J Radiat Biol       Date:  1997-05       Impact factor: 2.694

4.  Inhibition of apoptosis as a mechanism of tumor promotion.

Authors:  S C Wright; J Zhong; J W Larrick
Journal:  FASEB J       Date:  1994-06       Impact factor: 5.191

Review 5.  Therapy of cancer metastasis by activation of the inducible nitric oxide synthase.

Authors:  K Xie; I J Fidler
Journal:  Cancer Metastasis Rev       Date:  1998-03       Impact factor: 9.264

Review 6.  Apoptosis. Its significance in cancer and cancer therapy.

Authors:  J F Kerr; C M Winterford; B V Harmon
Journal:  Cancer       Date:  1994-04-15       Impact factor: 6.860

7.  Toxic and carcinogenic agents in dry and moist snuff.

Authors:  D Hoffmann; J D Adams; D Lisk; I Fisenne; K D Brunnemann
Journal:  J Natl Cancer Inst       Date:  1987-12       Impact factor: 13.506

8.  Nitric oxide induces apoptosis in mouse thymocytes.

Authors:  K Fehsel; K D Kröncke; K L Meyer; H Huber; V Wahn; V Kolb-Bachofen
Journal:  J Immunol       Date:  1995-09-15       Impact factor: 5.422

9.  Nitric oxide induces upregulation of Fas and apoptosis in vascular smooth muscle.

Authors:  K Fukuo; S Hata; T Suhara; T Nakahashi; Y Shinto; Y Tsujimoto; S Morimoto; T Ogihara
Journal:  Hypertension       Date:  1996-03       Impact factor: 10.190

10.  Tobacco specific N-nitrosamines: occurrence and bioassays.

Authors:  D Hoffmann; J D Adams; K D Brunnemann; A Rivenson; S S Hecht
Journal:  IARC Sci Publ       Date:  1982
View more
  4 in total

Review 1.  Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco.

Authors:  Michael D Johnson; Jodi Schilz; Mirjana V Djordjevic; Jerry R Rice; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

2.  Nicotine induces upregulated expression of beta defensin-2 via the p38MAPK pathway in the HaCaT human keratinocyte cell line.

Authors:  Sumiko Nakamura; Masato Saitoh; Mami Yamazaki; Michiko Nishimura; Yoshihito Kurashige; Toshiya Arakawa; Taishin Takuma; Tohru Kaku; Yoshihiro Abiko
Journal:  Med Mol Morphol       Date:  2011-01-26       Impact factor: 2.309

3.  FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation.

Authors:  Emilios Gemenetzidis; Amrita Bose; Adeel M Riaz; Tracy Chaplin; Bryan D Young; Muhammad Ali; David Sugden; Johanna K Thurlow; Sok-Ching Cheong; Soo-Hwang Teo; Hong Wan; Ahmad Waseem; Eric K Parkinson; Farida Fortune; Muy-Teck Teh
Journal:  PLoS One       Date:  2009-03-16       Impact factor: 3.240

4.  Smokeless tobacco extract inhibits proliferation and promotes apoptosis in oral mucous fibroblasts.

Authors:  Lei Li; Xiaoqing Zhou; Yanran Wang
Journal:  Oncol Lett       Date:  2018-08-02       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.